Company Filing History:
1 out of 1,217 
1 out of 1 
1 out of 3,687 
Years Active: 1998-1999
Title: Michael Kassiou: Innovator in Radiolabeled Compounds
Introduction
Michael Kassiou is a notable inventor based in Marrickville, Australia. He has made significant contributions to the field of radiolabeled compounds, particularly in the imaging of nicotinic cholinergic receptors in the brain. With a total of 2 patents, Kassiou's work is pivotal for both research studies and the diagnosis of neurodegenerative diseases.
Latest Patents
Kassiou's latest patents include "Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes" and "Method for imaging nicotinic acetylcholinergic receptors in the brain." These inventions focus on radiolabeled epibatidine analogues, specifically FPH labeled with radioisotopes of fluorine and/or carbon. The compounds developed through these patents are designed to noninvasively image and quantify nicotinic cholinergic receptors in the living brain.
Career Highlights
Throughout his career, Kassiou has worked with esteemed organizations, including the United States of America as represented by the Department of Health. His innovative work has contributed to advancements in medical imaging and the understanding of neurodegenerative diseases.
Collaborations
Kassiou has collaborated with notable colleagues such as Edythe D London and Alane S Kimes. These partnerships have further enhanced the impact of his research and inventions.
Conclusion
Michael Kassiou's contributions to the field of radiolabeled compounds are significant and impactful. His patents play a crucial role in advancing medical research and diagnostics.